News 03.10.2022 Schlieren (Zurich), Switzerland, October 3, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that it has appointed Chris Fair as Chief Operating Officer (COO). Mr. Fair is a leader in the musculoskeletal and regenerative medicine industry with more than 25...
Events, Internal events
Event date: 04.10.2022
Date and time: October 4th, 2022 – 12pm
Venue: Auditorium, Wagistrasse 25, 8952 Schlieren
DiNAQOR
Invites you to join a lecture on:
“Adeno-Associated Virus and the human liver; biology, vectorology and therapeutics”
by
Professor Ian Alexander BMedSci, MBBS (Hons), FRACP, PhD, HGSACG, FAHMS
Head, Gene Therapy Research Unit, Sydney Children’s Hospitals Network and Children’s Medical Research Institute
Professor in...
Events, Internal events
Event date: 03.11.2022
After the long Covid break forced on all of us, it is time again to meet people and exchange ideas. Because there are some interesting developments going on in the patent field at the moment, we would like to draw your attention to a seminar event
on 3 November 2022 at...
News 15.09.2022 Schlieren (Zurich), Switzerland, September 15, 2022 – Kuros Biosciences AG (SIX:KURN) a leader in next generation bone graft technologies, announced today the successful completion of a CHF 6.0 million capital increase through a private placement of 3,750,000 new shares of Kuros with a par value of CHF 0.10 each (the...
Events, Internal events
Event date: 13.10.2022
Date: Thursday, 13th October 2022
Time: 4pm - 6pm CEST
Address: Bio-Technopark Schlieren-Zürich, Auditorium, Wagistrasse 25, CH-8952 Schlieren
Parenteral Drug Product: formulation development, capability, and strategy
Join us for the face-to-face event and meet our experts
Lonza’s Parenteral Drug Product Services has been experiencing fast growth over the last years and today provides fully integrated,...